Audit 299213

FY End
2023-06-30
Total Expended
$4.31M
Findings
0
Programs
9
Year: 2023 Accepted: 2024-03-28

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
PCKFBH4PHA42 Jennison Bielemeier Auditee
5855457182 Michael Schoell Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. The information in this Schedule is presented in accordance with the requirements of Uniform Guidance. Trillium has elected to use the 10% de minimis cost rate as allowed under the Uniform Guidance. De Minimis Rate Used: Y Rate Explanation: Trillium has elected to use the 10% de minimis cost rate as allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of Trillium Health, Inc. d/b/a Trillium Health and Trillium Health Pharmacy (collectively, “Trillium”) under programs of the federal government for the year ended June 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (“Uniform Guidance”). Because the Schedule presents only a selected portion of the operations of Trillium, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Trillium.